Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk
- PMID: 21059108
- DOI: 10.1111/j.1432-2277.2010.01159.x
Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk
Abstract
Cardiovascular disease is the leading cause of death following renal transplantation, and renal transplant patients have a greatly increased cardiac risk compared with the general population. Death with a functioning graft caused by cardiovascular disease also represents a substantial cause of graft loss. Decreased renal function in transplant recipients is a major contributor to increased cardiac risk, both as an independent risk factor and because of its negative effects on hypertension, anemia, left ventricular hypertrophy, and dyslipidemia. Graft loss and diabetes mellitus are also significant risk factors for cardiac death. Although critical for maintaining the transplanted organs, standard immunosuppressants have toxicities that exacerbate cardiac risk. Preservation of renal function, prevention of graft loss, and reductions in cardiovascular risk factors via improvements in both patient management and immunosuppressive therapies constitute critical strategies for optimizing patient and graft survival over the long term.
© 2010 The Authors. Transplant International © 2010 European Society for Organ Transplantation.
Similar articles
-
[Cardiovascular disease after renal transplantation].G Ital Nefrol. 2004 Jan-Feb;21 Suppl 26:S53-66. G Ital Nefrol. 2004. PMID: 15732047 Review. Italian.
-
The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.J Nephrol. 2002 Jul-Aug;15(4):380-6. J Nephrol. 2002. PMID: 12243367
-
[Late complications following renal transplantation].Ned Tijdschr Geneeskd. 2008 Jun 7;152(23):1317-21. Ned Tijdschr Geneeskd. 2008. PMID: 18661857 Review. Dutch.
-
Cardiovascular risk factors in renal transplantation--current controversies.Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii3-8. doi: 10.1093/ndt/gfl298. Nephrol Dial Transplant. 2006. PMID: 16815854
-
[Hypertension after kidney transplantation].Lijec Vjesn. 2006 Nov-Dec;128(11-12):373-8. Lijec Vjesn. 2006. PMID: 17212200 Review. Croatian.
Cited by
-
Long-Term Treatment of Azathioprine in Rats Induces Vessel Mineralization.Biomedicines. 2021 Mar 23;9(3):327. doi: 10.3390/biomedicines9030327. Biomedicines. 2021. PMID: 33806932 Free PMC article.
-
Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization.PLoS One. 2014 Jul 16;9(7):e101709. doi: 10.1371/journal.pone.0101709. eCollection 2014. PLoS One. 2014. PMID: 25029363 Free PMC article.
-
Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients.Ren Fail. 2024 Dec;46(1):2300303. doi: 10.1080/0886022X.2023.2300303. Epub 2024 Jan 23. Ren Fail. 2024. PMID: 38263697 Free PMC article.
-
A pilot randomised controlled trial of a structured, home-based exercise programme on cardiovascular structure and function in kidney transplant recipients: the ECSERT study design and methods.BMJ Open. 2021 Oct 5;11(10):e046945. doi: 10.1136/bmjopen-2020-046945. BMJ Open. 2021. PMID: 34610929 Free PMC article. Clinical Trial.
-
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients.Rev Cardiovasc Med. 2022 Sep 13;23(9):311. doi: 10.31083/j.rcm2309311. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077719 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical